( NASDAQ-SMALL:INSM )

News from Insmed Incorporated A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

13 Dec, 2012, 08:00 ET Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies...


13 Nov, 2012, 08:00 ET Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Has Completed Target Enrollment

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...


12 Nov, 2012, 08:00 ET Insmed To Present At Two Upcoming Investor Conferences

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...


07 Nov, 2012, 07:15 ET Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...


07 Nov, 2012, 07:00 ET Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...


24 Oct, 2012, 08:00 ET Insmed to Host 2012 Third Quarter Earnings Conference Call

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering...


28 Sep, 2012, 08:23 ET Insmed Announces Pricing of Approximately $26 Million Direct Public Offering

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering...


11 Sep, 2012, 08:00 ET Insmed Appoints Will Lewis as President and Chief Executive Officer

 Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering...


30 Aug, 2012, 08:00 ET Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...


14 Aug, 2012, 08:00 ET Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...


07 Aug, 2012, 07:00 ET Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the...


06 Aug, 2012, 08:00 ET Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...


02 Aug, 2012, 08:00 ET Insmed Receives Second Composition Of Matter Patent For ARIKACE®

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...


30 Jul, 2012, 08:00 ET Insmed Announces Planned Departure Of Chief Financial Officer

MONMOUTH JUNCTION, N.J., July 30, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on...


24 Jul, 2012, 08:00 ET Insmed to Host 2012 Second Quarter Earnings Conference Call

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the lung,...


10 Jul, 2012, 08:00 ET Insmed To Present At JMP Securities 7th Annual Healthcare Conference

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...


02 Jul, 2012, 08:00 ET Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the...


27 Jun, 2012, 08:00 ET Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycobacteria (NTM) Lung Disease

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the first patient has been dosed in the Company's...


23 May, 2012, 08:00 ET Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2...


16 May, 2012, 08:00 ET Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced the appointments of Donald J. Hayden, Jr. as Executive Chairman...


08 May, 2012, 07:00 ET Insmed Announces First Quarter 2012 Financial Results

 Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, today reported results for the first quarter ended March 31, 2012. Key...


07 May, 2012, 08:00 ET Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has lifted the...


24 Apr, 2012, 08:00 ET Insmed to Host 2012 First Quarter Earnings Conference Call

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, will host a conference call on Tuesday, May 8th, 2012, at 8:30 AM ET, to...


16 Apr, 2012, 08:00 ET Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections

 Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced the initiation of the Company's CLinical Evaluation of...


13 Mar, 2012, 07:00 ET Insmed Announces Fourth Quarter and Full-Year 2011 Financial Results

Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the fourth quarter and fiscal year ended December...